Literature DB >> 2473326

The fate of radioiodinated endothelin-1 and endothelin-3 in the rat.

E Anggård1, S Galton, G Rae, R Thomas, L McLoughlin, G de Nucci, J R Vane.   

Abstract

Endothelin-1 (ET-1) has been isolated from cultured endothelial cells and might have a role in cardiovascular regulation. To study the fate of labeled ET-1, we prepared [125I]-labeled ET-1 (formerly porcine and human ET) and ET-3 (formerly rat ET). Approximately 0.2 microCi (0.2 pmol) was injected into the left ventricle of anesthetized rats and blood samples analyzed for radioactivity for up to 40 min. The animals were then killed and the distribution of radioactivity determined in various organs. Both ET-1 and ET-3 were rapidly removed from the circulation, with more than 60% of the removal occurring in the first minute. Removal of ET-1 was somewhat faster than that of ET-3. The highest uptake of radioactivity was seen in lung, kidney, and liver. When ET-1 was infused into the isolated perfused lung of the guinea pig, 64 +/- 1.9% of the label was retained. Subcellular fractionation of the lung homogenate following infusion of labeled ET-1 showed that 93% of the label was associated with membranes and intracellular organelles, suggesting internalization of the bound ET-1. Together, the results indicate a high density of ET-1 binding sites in the lung, liver, and kidney and that these organs may be important in removing circulating ET-1.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473326     DOI: 10.1097/00005344-198900135-00012

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  14 in total

Review 1.  Endothelium-dependent vascular responses. Mediators and mechanisms.

Authors:  B M Brenner; J L Troy; B J Ballermann
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

2.  Nitric oxide modulates renal vasoconstrictor effect of endothelin-1 in conscious lambs.

Authors:  Francine G Smith; Liesbeth van der Velde; Alp Sener
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

Review 3.  Endothelin in heart failure.

Authors:  G Sütsch; M Barton
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

4.  Endothelin-1 mRNA is widely expressed in porcine and human tissues.

Authors:  D J Nunez; M J Brown; A P Davenport; C B Neylon; J P Schofield; R K Wyse
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

5.  Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.

Authors:  T D Warner; G H Allcock; J R Vane
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Regional haemodynamic responses to intravenous and intraarterial endothelin-1 and big endothelin-1 in conscious rats.

Authors:  S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

7.  Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes.

Authors:  C R Gandhi; R H Behal; S A Harvey; T A Nouchi; M S Olson
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

Review 8.  The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?

Authors:  N S Kirkby; P W F Hadoke; A J Bagnall; D J Webb
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

9.  The influence of endothelin-1 on human foeto-placental blood vessels: a comparison with 5-hydroxytryptamine.

Authors:  M R MacLean; A G Templeton; J C McGrath
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

10.  Hemodynamic and inotropic effects of endothelin-1 in vivo.

Authors:  M E Beyer; S Nerz; B K Krämer; H M Hoffmeister
Journal:  Basic Res Cardiol       Date:  1994 Jan-Feb       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.